The DxH 900 Hematology Analyzer delivers accurate, first-analysis results through proprietary VCS technology. With fewer slide reviews and high system reliability for maximum uptime, this powerful analyzer streamlines processes to maximize laboratory staff time. The analyzer is compatible with clinical informatics and automation solutions to form scalable, customized solutions.
Achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization
Deliver reliable, reportable WBC differential results on the first run, through VCS technology, DataFusion and the enhanced Coulter Principle. These core technologies provide high-resolution characterization without altering cell morphology, providing excellent hematological test results
Support critical clinical decisions through advanced PLT analysis. The enhanced Coulter
Principle provides a reportable MPV—even for thrombocytopenic patients—while DataFusion leverages inter-module intelligence to enable improved flagging and identification of interferences
Assess anemia with accuracy by maintaining near native-state cellular characterization throughout the RBC maturation cycle
Facilitate confident slide interpretations through intelligent slide-making. Hemasphere
technology analyzes blood viscosity to optimize smearing, and DxH Slidemaker Stainer II ensures consistent slide quality
Ensure predictable costs and >30% faster break-even point
Experience low cost of ownership through a 93% first-pass yield and predictable reagent consumption
Reduce manual interventions with automated maintenance procedures and less reagent turnover to maximize walkaway time